Latest news
Loading news…
Ouro Medicines
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Francisco, California, United States Founded 2025 11-50 employees For Profit
Ouroboros Medicines is a biotechnology company specializes in immunology.
Ouro Medicines was acquired by Gilead Sciences in 2026 for $2M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- IT spend
- $45K
Company Info
- Founded
- 2025
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 88
- HQ
- San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- Mar 23, 2026
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -1.1
- Trend (90d)
- -5.3
- Last leadership hire
- Jan 16, 2025
Key People at Ouro Medicines
CMO and Head of Development
Chief Development Officer
General Counsel and Chief Administrative Officer
CEO & Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Ouro Medicines
Loading news…
FAQs about Ouro Medicines
People who checked this page also checked these
Browse the full Acquirezy directory.